Recent Articles
Posted By: NSGC Headquarters
Tue May 15th, 2018
I remember it all so vividly: Our conscientious and compassionate geneticists had given us an ultra-rare diagnosis: hereditary spastic paraplegia type 47 (SPG47). There were nine others diagnosed in the world that they knew of at that time, and no one was researching treatment.
Posted By: NSGC Headquarters
Tue May 15th, 2018
Some might say our story is tragic, worrisome, and full of heartache and loss. But thanks be to God, who in His perfect timing placed in our lives a brilliant medical team and genetic counselor, Benjamin M. Helm. Because of Ben, we can say our story is one of life, miracles, love, and hope.
Posted By: NSGC Headquarters
Tue May 15th, 2018
Our relationship with Melanie began after our son, Adam, and future daughter-in-law, Anne, went through genetic testing before their wedding. Based on their results, my husband and I were referred for testing as well. Adam had previously been diagnosed with myotonia congenita, a rare genetic
Posted By: Scott M. Weissman
Thu Apr 26th, 2018
From Information and Entertainment to Actionable Medical Tests
If you were a fan of the Winter Olympics like I was, perhaps you saw the seemingly endless parade of TV commercials for AncestryDNA and 23andMe, two of the biggest direct-to-consumer (DTC) genetic testing companies. If you are not fami
Posted By: NSGC Headquarters
Thu Apr 19th, 2018
The U.S. Food and Drug Administration approved the marketing of 23andMe Personal Genome Service Genetic Health Risk Report for BRCA1/BRCA2 on March 6, 2018. This is the first direct-to-consumer (DTC) test to report on three specific breast cancer gene mutations most common in people of Ashkenazi (Ea
